These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3128135)

  • 1. Treatment of childhood epilepsy with rectal valproate: case reports and pharmacokinetic study.
    Kanazawa O; Sengoku A; Kawai I
    Brain Dev; 1987; 9(6):615-20. PubMed ID: 3128135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Valproate versus diazepam for generalized convulsive status epilepticus: a pilot study.
    Chen WB; Gao R; Su YY; Zhao JW; Zhang YZ; Wang L; Ren Y; Fan CQ
    Eur J Neurol; 2011 Dec; 18(12):1391-6. PubMed ID: 21557791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronopharmacokinetic study of valproic acid in man: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ogawa N
    J Clin Pharmacol; 1989 Nov; 29(11):1048-52. PubMed ID: 2513338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal administration of sodium valproate in children.
    Scanabissi E; Dal Pozzo D; Franzoni E; Galloni C; Mengoli G; Calivà R
    Ital J Neurol Sci; 1984 Jun; 5(2):189-93. PubMed ID: 6432726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and clinical application of intravenous valproate in Thai epileptic children.
    Visudtibhan A; Bhudhisawadi K; Vaewpanich J; Chulavatnatol S; Kaojareon S
    Brain Dev; 2011 Mar; 33(3):189-94. PubMed ID: 20444563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valproate unbound fraction and distribution volume following rapid infusions in patients with epilepsy.
    Cloyd JC; Dutta S; Cao G; Walch JK; Collins SD; Granneman GR;
    Epilepsy Res; 2003 Feb; 53(1-2):19-27. PubMed ID: 12576164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy.
    Dedeurwaerdere S; van Raay L; Morris MJ; Reed RC; Hogan RE; O'Brien TJ
    Seizure; 2011 Jan; 20(1):72-9. PubMed ID: 21093310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsy.
    Imaizumi T; Izumi T; Fukuyama Y
    Brain Dev; 1992 Sep; 14(5):304-8. PubMed ID: 1456384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of intravenous valproate].
    Adín J; Arteaga R; Herranz JL; Armijo JA
    Rev Neurol; 1999 Oct 16-31; 29(8):744-53. PubMed ID: 10560111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of valproate in adults after a single loading dose.
    Giroud M; Dumas R
    Arch Neurol; 1989 Jan; 46(1):13-4. PubMed ID: 2491943
    [No Abstract]   [Full Text] [Related]  

  • 12. Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performances.
    Brouwer OF; Pieters MS; Edelbroek PM; Bakker AM; van Geel AA; Stijnen T; Jennekens-Schinkel A; Lanser JB; Peters AC
    Epilepsy Res; 1992 Dec; 13(3):245-53. PubMed ID: 1493787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronopharmacological study of valproic acid in mice: comparison of oral and rectal administration.
    Yoshiyama Y; Nakano S; Ohdo S; Ogawa N
    J Pharmacobiodyn; 1992 Aug; 15(8):403-8. PubMed ID: 1479540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral/intravenous maintenance dosing of valproate following intravenous loading: a simulation.
    Dutta S; Cloyd JC; Granneman GR; Collins SD
    Epilepsy Res; 2003 Feb; 53(1-2):29-38. PubMed ID: 12576165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of intravenous valproate in pediatric status epilepticus and acute repetitive seizures.
    Yu KT; Mills S; Thompson N; Cunanan C
    Epilepsia; 2003 May; 44(5):724-6. PubMed ID: 12752474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral rapid loading of valproic acid--an alternative to the usual saturation scheme?
    Gerstner T; Bell N; Longin E; König SA
    Seizure; 2006 Dec; 15(8):630-2. PubMed ID: 17070075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic parameters of total and unbound valproic acid and their relationships to seizure control in epileptic children.
    Panomvana Na Ayudhya D; Suwanmanee J; Visudtibhan A
    Am J Ther; 2006; 13(3):211-7. PubMed ID: 16772762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effectiveness of several formulations of sodium valproate: tablets, enteric-coated capsules, solutions and rectal capsules.
    Battino D; Biraghi M; Cusi C; Nespolo A; Avanzini G
    Ital J Neurol Sci; 1982 Oct; 3(3):197-200. PubMed ID: 6819250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, anticonvulsant efficacy, and adverse effects of trans-2-en-valproate after acute and chronic administration in amygdala-kindled rats.
    Hönack D; Rundfeldt C; Löscher W
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Feb; 345(2):187-96. PubMed ID: 1570023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.